Kestra Medical Technologies, Ltd. (KMTS)
KMTS Stock Price Chart
Explore Kestra Medical Technologies, Ltd. interactive price chart. Choose custom timeframes to analyze KMTS price movements and trends.
KMTS Company Profile
Discover essential business fundamentals and corporate details for Kestra Medical Technologies, Ltd. (KMTS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
6 Mar 2025
Employees
300.00
Website
https://kestramedical.comCEO
Brian Webster
Description
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
KMTS Financial Timeline
Browse a chronological timeline of Kestra Medical Technologies, Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Sept 2026
EPS estimate is -$0.63, while revenue estimate is $29.01m.
Earnings released on 14 Jul 2026
EPS came in at -$0.67 falling short of the estimated -$0.59 by -13.56%, while revenue for the quarter reached $28.64m , beating expectations by +8.15%.
Earnings released on 17 Mar 2026
EPS came in at -$0.61 falling short of the estimated -$0.60 by -1.67%, while revenue for the quarter reached $24.55m , beating expectations by +7.35%.
Earnings released on 11 Dec 2025
EPS came in at -$0.62 falling short of the estimated -$0.59 by -4.36%, while revenue for the quarter reached $22.57m , missing expectations by -1.34%.
Earnings released on 11 Sept 2025
EPS came in at -$0.46 surpassing the estimated -$0.66 by +30.30%, while revenue for the quarter reached $19.37m , missing expectations by -6.54%.
Earnings released on 17 Jul 2025
EPS came in at -$1.05 , while revenue for the quarter reached $17.23m .
Earnings released on 14 Apr 2025
EPS came in at -$1.25 falling short of the estimated -$0.60 by -107.18%, while revenue for the quarter reached $15.09m , beating expectations by +0.12%.
Earnings released on 30 Apr 2024
EPS came in at -$0.45 , while revenue for the quarter reached $10.05m .
Earnings released on 31 Jan 2024
EPS came in at -$0.44 , while revenue for the quarter reached $8.28m .
Earnings released on 31 Jul 2021
EPS came in at -$0.27 .
KMTS Stock Performance
Access detailed KMTS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
